Literature DB >> 2531848

Sensitivity to cyclosporin A is mediated by cyclophilin in Neurospora crassa and Saccharomyces cerevisiae.

M Tropschug1, I B Barthelmess, W Neupert.   

Abstract

Cyclosporin A, a cyclic fungal undecapeptide produced by Tolypocladium inflatum, is a potent immunosuppressive drug originally isolated as an antifungal antibiotic. Cyclosporin A (CsA) is widely used in humans to prevent rejection of transplanted organs such as kidney, heart, bone marrow and liver. The biochemical basis of CsA action is not known: its primary cellular target has been suggested to be calmodulin, the prolactin receptor or cyclophilin, a CsA-binding protein originally isolated from the cytosol of bovine thymocytes. Cyclophilin has been shown to be a highly conserved protein present in all eukaryotic cells tested and to be identical to peptidyl-prolyl cis-trans isomerase, a novel type of enzyme that accelerates the slow refolding phase of certain proteins in vitro. We demonstrate that in the lower eukaryotes N. crassa and S. cerevisiae, cyclo philin mediates the cytotoxic CsA effect. In CsA-resistant mutants of both organisms, the cyclophilin protein is either lost completely or, if present, has lost its ability to bind CsA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2531848     DOI: 10.1038/342953a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  66 in total

1.  A Cyanobacterial Gene Encoding Peptidyl-Prolyl cis-trans Isomerase.

Authors:  M Hassidim; R Schwarz; J Lieman-Hurwitz; E Marco; M Ronen-Tarazi; A Kaplan
Journal:  Plant Physiol       Date:  1992-12       Impact factor: 8.340

2.  FKBP12 physically and functionally interacts with aspartokinase in Saccharomyces cerevisiae.

Authors:  C M Alarcón; J Heitman
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

Review 3.  A brief review of modern toxicologic pathology in regulatory and explanatory toxicity studies of chemicals.

Authors:  R A Ettlin; M Oberholzer; E Perentes; B Ryffel; M Kolopp; S R Qureshi
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

4.  Overexpression, purification, and characterization of yeast cyclophilins A and B.

Authors:  L D Zydowsky; S I Ho; C H Baker; K McIntyre; C T Walsh
Journal:  Protein Sci       Date:  1992-08       Impact factor: 6.725

5.  Differential expression of cyclophilin isoforms during keratinocyte differentiation.

Authors:  D Chatellard-Gruaz; J H Saurat; G Siegenthaler
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

6.  Purification and N-terminal sequencing of peptidyl-prolyl cis-trans-isomerase from rat liver mitochondrial matrix reveals the existence of a distinct mitochondrial cyclophilin.

Authors:  C P Connern; A P Halestrap
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

Review 7.  Probing T-cell signal transduction pathways with the immunosuppressive drugs, FK-506 and rapamycin.

Authors:  J J Siekierka
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

8.  Nucleotide sequence of a full-length cDNA coding for cyclophilin (peptidyl-prolyl cis-trans isomerase) of Saccharomyces cerevisiae.

Authors:  K Dietmeier; M Tropschug
Journal:  Nucleic Acids Res       Date:  1990-01-25       Impact factor: 16.971

9.  Peptidyl-prolyl cis-trans-isomerase from Escherichia coli: a periplasmic homolog of cyclophilin that is not inhibited by cyclosporin A.

Authors:  J Liu; C T Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

10.  The immunosuppressant FK506 inhibits amino acid import in Saccharomyces cerevisiae.

Authors:  J Heitman; A Koller; J Kunz; R Henriquez; A Schmidt; N R Movva; M N Hall
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.